Skip to main content
Premium Trial:

Request an Annual Quote

Arcis Biotechnology: Steve Howell

Arcis Biotechnology, a nucleic acid sample prep provider, has appointed Steve Howell as non-executive chairman of the board. Howell will replace Paul Foulger, who was serving as chairman of the board on an interim basis. Howell is a professor of commercial innovation at King's College, London, a position he has held since 2015. He founded Innova Partnerships in 2006, and has previously served as director of business development at Alere and research director at Unipath.

The Scan

Could Mix It Up

The US Food and Drug Administration is considering a plan that would allow for the mixing-and-matching of SARS-CoV-2 vaccines and boosters, the New York Times says.

Closest to the Dog

New Scientist reports that extinct Japanese wolf appears to be the closest known wild relative of dogs.

Offer to Come Back

The Knoxville News Sentinel reports that the University of Tennessee is offering Anming Hu, a professor who was acquitted of charges that he hid ties to China, his position back.

PNAS Papers on Myeloid Differentiation MicroRNAs, Urinary Exosomes, Maize Domestication

In PNAS this week: role of microRNAs in myeloid differentiation, exosomes in urine, and more.